Gérard Pons

8.9k citations

200 papers · 6.5k indexed · 1 hit paper · h-index 45

Impact in

Pediatrics, Perinatology and Child Health top 0.2%
- Pharmacological Effects and Toxicity Studies
- Pharmaceutical studies and practices
Psychiatry and Mental health top 0.5%
- Epilepsy research and treatment

Papers in

Pediatrics, Perinatology and Child Health 78
- Pharmaceutical studies and practices 41
- Pharmacological Effects and Toxicity Studies 33
Psychiatry and Mental health 37
- Epilepsy research and treatment 36

Co-authors: Elisabeth Rey Jean‐Marc Tréluyer Vincent Jullien Catherine Chiron Olivier Dulac Sergi Ganau Robert Martí Jean‐Louis Vincent
Journals: British Journal of Clinical Pharmacology (15 papers)Clinical Pharmacology & Therapeutics (11 papers)European Journal of Clinical Pharmacology (9 papers)Antimicrobial Agents and Chemotherapy (8 papers)Materials and Structures (7 papers)
Partner nations: France Netherlands United Kingdom

In The Last Decade

Gérard Pons

191 papers receiving 6.2k citations

Hit Papers

align trajectories log scale

Automated Breast Ultrasound Lesions Detection Using Convolutional Neural Networks 2017 · 680 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 IEEE Journal of Biomedical and Health Informatics

Peers

Countries citing papers authored by Gérard Pons

Since Specialization

Citations

This map shows the geographic impact of Gérard Pons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérard Pons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérard Pons more than expected).

Fields of papers citing papers by Gérard Pons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gérard Pons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérard Pons. The network helps show where Gérard Pons may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gérard Pons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gérard Pons Line = papers co-authored together Gérard Pons links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Outcomes of extremely preterm infants who participated in a randomised trial of dopamine for treatment of hypotension (the HIP trial) at 2 years corrected age Archives of Disease in Childhood Fetal & Neonatal ·Neil Marlow, Keith J. Barrington, Ana Paula Freire, Jan Miletín, Gunnar Naulaers, Po‐Yin Cheung, J D Corcoran, Hugo Girousse, Geraldine B. Boylan, Vicki Livingstone, Gérard Pons, Zbyněk Straňák, David Van Laere, Carene Klintworth, Angie Mónica Cerna Núñez, Eugene Dempsey	2025	1
2	Hypotension in Preterm Infants (HIP) randomised trial Archives of Disease in Childhood Fetal & Neonatal ·Eugene Dempsey, Keith J. Barrington, Neil Marlow, Ana Paula Freire, Jan Miletín, Gunnar Naulaers, Po‐Yin Cheung, J D Corcoran, Afif El‐Khuffash, Geraldine B. Boylan, Vicki Livingstone, Gérard Pons, Carene Klintworth, David Van Laere, Angie Mónica Cerna Núñez, Zbyněk Straňák	2021	46
3	Management of Hypotension in Preterm Infants (The HIP Trial): A Randomised Controlled Trial of Hypotension Management in Extremely Low Gestational Age Newborns Neonatology ·Eugene Dempsey, Keith J. Barrington, Neil Marlow, Colm P. O’Donnell, Jan Miletín, Gunnar Naulaers, Po‐Yin Cheung, David Corcoran, Gérard Pons, Zbyněk Straňák, David Van Laere	2014	47
4	Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy Epilepsia ·Stéphanie Chhun, Vincent Jullien, Elisabeth Rey, Olivier Dulac, Catherine Chiron, Gérard Pons	2009	48
5	Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection Journal of Chromatography B ·Stéphanie Chhun, Elisabeth Rey, Agnès Tran, Olivier Lortholary, Gérard Pons, Vincent Jullien	2007	81
6	Quantification of darunavir (TMC114) in human plasma by high-performance liquid chromatography with ultra-violet detection Journal of Chromatography B ·Lauriane Goldwirt, Stéphanie Chhun, Elisabeth Rey, Odile Launay, Jean‐Paul Viard, Gérard Pons, Vincent Jullien	2007	40
7	Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study Annals of Oncology ·J. Alexandre, Elisabeth Rey, V. Girre, Sophie Grabar, A. Tran, L. Martins, B. Draniewicz, Véronique Dièras, Vincent Jullien, Patrice Herait, Gérard Pons, Jean‐Marc Tréluyer, François Goldwasser	2006	51
8	Méthodes de surveillance et de gestion des risques des médicaments pour la future mère, l’embryon, le fœtus et le nouveau-né Therapies ·Évelyne Jacqz-Aigrain, Véronique Lamarque, E. Autret‐Leca, Laurent Becquemont, Marie‐Jeanne Boutroy, 周菊林, A Castot, C Cornu, Christine Damase‐Michel, 九重常男, Elisabeth Dohin, 斌郑, C. Kreft-Jaïs, Hervé Le Louët, Luqi Gao, Adilson Oliveira dos Santos, Gérard Pons, D. Subtil, Thierry Vial	2006	2
9	Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus American Journal of Obstetrics and Gynecology ·Hélène Chappuy, Jean‐Marc Tréluyer, Elisabeth Rey, Jérôme Dimet, Monsur Ahmed, Efkan Canşen, Sanjeev D Kulkarni, Gérard Pons, Laurent Mandelbrot	2004	42
10	Oxcarbazepine Pharmacokinetics and Tolerability in Children With Inadequately Controlled Epilepsy The Journal of Clinical Pharmacology ·Elisabeth Rey, Christine Bulteau, Jacques Motté, Agnès Tran, Y. Sturm, Joseph D’Souza, S. Markabi, Gérard Pons, Olivier Dulac	2004	33
11	Determination of tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detection Journal of Chromatography B ·Vincent Jullien, Jean‐Marc Tréluyer, Gérard Pons, Elisabeth Rey	2003	60
12	[How to improve drug development and utilization in pediatrics]. PubMed ·Gérard Pons, Camille Lassale, Nang Muay Noan	2000	5
13	Quoi de neuf en pharmacologie pédiatrique ? Archives de Pédiatrie ·Jean‐Marc Tréluyer, Gérard Pons	2000	6
14	Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: In vitro and in vivo comparison and calculation of in vivo inhibition constants* Clinical Pharmacology & Therapeutics ·Agnès Tran, Elisabeth Rey, Gérard Pons, Marina Rousseau, Philippe d’Athis, Georges Olive, Gary Mather, Jens-Ole Jensen, Sarah Treadwell, Rita Labroo, William Trager, Kent L. Kunze, Kenneth E. Thummel, 陽子杉野目, J. M. Gillardin, F. Lepage, René H. Levy	1997	89
15	Isoniazid acetylation metabolic ratio during maturation in children Clinical Pharmacology & Therapeutics ·Ann Pariente‐Khayat, Elisabeth Rey, D Gendrel, F Vauzelle-Kervroëdan, Sever Ionescu, Philippe d’Athis, J Badoual, Georges Olive, Gérard Pons	1997	41
16	EXTENSION DU DOMAINE D'APPLICATION DES REGLEMENTS DE CALCUL BAEL/BPEL AUX BETONS A 80 MPa - JUSTIFICATIONS SCIENTIFIQUES DES PROPOSITIONS AVANCEES - CALCUL DES DEFORMATIONS INSTANTANEES ET DIFFEREES DES BETONS A HAUTES PERFORMANCES Robert Le Roy, F De Larrard, Gérard Pons	1996	1
17	A randomized, double‐blind, multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children Fundamental and Clinical Pharmacology ·L. Bertin, Gérard Pons, P D’Athis, J.F. Duhamel, 刘飞锋, G Lasfargues, M Guillot, H. Ohlhoff, Sofyan Maulana, G Olivé	1996	81
18	RETRAIT ET FLUAGE DE BETONS A HAUTES PERFORMANCES : DONNEES POUR LE CALCUL DES DEFORMATIONS DIFFEREES David Hrachovec, Gérard Pons	1992	3
19	Pharmacokinetics of tiaprofenic acid in children after a single oral dose European Journal of Clinical Pharmacology ·L. Bertin, Elisabeth Rey, Gérard Pons, G.P. Rao, Marie‐Odile Richard, D. Pothmann, C Saint-Maurice, Claude Moran, David J. Shea, G Olivé	1991	6
20	Biological characterization of murine neuroblastoma: in vivo neurogenic tumor model. Abstr. The Mouseion at the JAXlibrary (Jackson Laboratory) ·Gérard Pons, Bernard L. Mirkin, Robert M. O’Dea	1981	1

About Gérard Pons

Gérard Pons is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health, Pharmacology, Pharmacology and Virology, having authored 200 papers that have together received 6.5k indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (41 papers), Epilepsy research and treatment (36 papers), Pharmacological Effects and Toxicity Studies (33 papers), Antibiotics Pharmacokinetics and Efficacy (32 papers), HIV/AIDS drug development and treatment (20 papers), Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (13 papers) and Metabolism and Genetic Disorders (10 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (2.4k citations), Psychiatry and Mental health (1.5k citations), Pharmacology (670 citations), Clinical Biochemistry (365 citations) and Anesthesiology and Pain Medicine (282 citations). Gérard Pons has collaborated with scholars based in France, Netherlands and United Kingdom. Frequent co-authors include Elisabeth Rey, Jean‐Marc Tréluyer, Vincent Jullien, Catherine Chiron, Olivier Dulac, Sergi Ganau, Robert Martí, Jean‐Louis Vincent, P D’Athis and Melcior Sentís. Their work appears in journals such as British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, European Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy and Materials and Structures.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact